Cabaletta Bio, Inc.

US$1.30As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CABAHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (25.73%)
Div yield —
ROE (89.52%)
Biotechnology
Beta (5Y) 3.54
PE TTM —
TSR TTM (63.99%)
Mkt cap US$280.4M
ROIC (51.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.37
5.39%
(34.66%)
Buy 3|7|9|2|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
10.80%
(2.87%)
10.39%
0.99%
Revenue$M
16.01
16.76
17.49
17.99
10.68%
13.70%
15.08%
16.79%
Peers (US$280.4M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
18.22
0.214
0.201
EBIT/Intx
1.345
0.104
0.112
Own earn%
97.78
318.35
291.25
Sh yield%
33.82
45.69
42.83
Owners
Insiders/Inst%
7.49
53.62
Short interest%
1.01
SBC / revenue%
4.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
25–31
$1 testx
—
Incr. ROIC%
9